DIAGNOS (CVE:ADK) Stock Price Up 20.8% – Should You Buy?

Shares of DIAGNOS Inc. (CVE:ADKGet Free Report) were up 20.8% during mid-day trading on Tuesday . The company traded as high as C$0.36 and last traded at C$0.29. Approximately 2,130,853 shares were traded during mid-day trading, an increase of 931% from the average session volume of 206,587 shares. The stock had previously closed at C$0.24.

DIAGNOS Price Performance

The company has a current ratio of 1.49, a quick ratio of 0.68 and a debt-to-equity ratio of 204.05. The firm has a market capitalization of C$34.92 million, a price-to-earnings ratio of -7.25 and a beta of -0.12. The company’s 50 day moving average is C$0.23 and its 200-day moving average is C$0.26.

About DIAGNOS

(Get Free Report)

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.

Featured Stories

Receive News & Ratings for DIAGNOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIAGNOS and related companies with MarketBeat.com's FREE daily email newsletter.